D
Denali Therapeutics Inc. DNLI
$15.15 $0.261.75%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- 0.00 1.27M 295.39M 330.53M
Total Other Revenue -- -- -- -- --
Total Revenue -- 0.00 1.27M 295.39M 330.53M
Cost of Revenue 319.41M 335.32M 326.82M 327.65M 349.45M
Gross Profit -319.41M -335.32M -325.55M -32.26M -18.91M
SG&A Expenses 105.44M 100.15M 100.52M 101.45M 103.35M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 501.88M 512.50M 504.38M 511.43M 535.13M
Operating Income -501.88M -512.50M -503.11M -216.04M -204.60M
Income Before Tax -422.71M -427.46M -419.62M -137.22M -145.19M
Income Tax Expenses 68.00K 30.00K 30.00K 30.00K 30.00K
Earnings from Continuing Operations -422.77 -427.49 -419.65 -137.25 -145.22
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -422.77M -427.49M -419.65M -137.25M -145.22M
EBIT -501.88M -512.50M -503.11M -216.04M -204.60M
EBITDA -495.23M -503.95M -494.61M -207.20M -187.87M
EPS Basic -2.58 -2.76 -2.85 -0.93 -1.05
Normalized Basic EPS -1.74 -1.92 -1.98 -0.78 -0.78
EPS Diluted -2.58 -2.77 -2.86 -0.97 -1.09
Normalized Diluted EPS -1.74 -1.92 -1.98 -0.80 -0.81
Average Basic Shares Outstanding 657.78M 625.94M 594.13M 562.34M 549.46M
Average Diluted Shares Outstanding 657.78M 625.94M 594.13M 566.22M 553.35M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings